IL100896A - תרופות נגד אסטמה הניתנות בשאיפה המכילות תרכובות אנטי-דלקתיות לא סטרוידליות - Google Patents

תרופות נגד אסטמה הניתנות בשאיפה המכילות תרכובות אנטי-דלקתיות לא סטרוידליות

Info

Publication number
IL100896A
IL100896A IL100896A IL10089692A IL100896A IL 100896 A IL100896 A IL 100896A IL 100896 A IL100896 A IL 100896A IL 10089692 A IL10089692 A IL 10089692A IL 100896 A IL100896 A IL 100896A
Authority
IL
Israel
Prior art keywords
unw
patients
inhalation
bronchial
effect
Prior art date
Application number
IL100896A
Other languages
English (en)
Other versions
IL100896A0 (en
Original Assignee
Sebastiano Bianco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sebastiano Bianco filed Critical Sebastiano Bianco
Publication of IL100896A0 publication Critical patent/IL100896A0/xx
Publication of IL100896A publication Critical patent/IL100896A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
IL100896A 1991-02-09 1992-02-07 תרופות נגד אסטמה הניתנות בשאיפה המכילות תרכובות אנטי-דלקתיות לא סטרוידליות IL100896A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101818 1991-02-09

Publications (2)

Publication Number Publication Date
IL100896A0 IL100896A0 (en) 1992-11-15
IL100896A true IL100896A (he) 1998-02-22

Family

ID=8206393

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100896A IL100896A (he) 1991-02-09 1992-02-07 תרופות נגד אסטמה הניתנות בשאיפה המכילות תרכובות אנטי-דלקתיות לא סטרוידליות

Country Status (16)

Country Link
US (1) US6051566A (he)
JP (1) JPH0648958A (he)
KR (1) KR920016086A (he)
AT (1) ATE179605T1 (he)
AU (1) AU662509B2 (he)
BR (1) BR9200429A (he)
CA (1) CA2060937A1 (he)
CZ (1) CZ281970B6 (he)
DE (1) DE69229070T2 (he)
HU (1) HUT60917A (he)
IE (1) IE920427A1 (he)
IL (1) IL100896A (he)
MX (1) MX9200571A (he)
NO (1) NO179893C (he)
NZ (1) NZ241542A (he)
ZA (1) ZA92890B (he)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
MXPA02001323A (es) 2000-05-10 2004-07-16 Alliance Pharma Microgranulos con base fosfolipida para la liberacion de farmaco.
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US7256184B2 (en) * 2000-10-16 2007-08-14 Rodriguez Victorio C Treatment of aging disorders in humans
US6759029B2 (en) * 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US6805853B2 (en) * 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
DE60230609D1 (de) * 2001-05-24 2009-02-12 Alexza Pharmaceuticals Inc Verabreichung von nichtsteroidalen entzündungshemmenden wirkstoffen durch inhalation
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
ES2316571T3 (es) * 2001-05-24 2009-04-16 Alexza Pharmaceuticals, Inc. Administracion de alprazolam, estazolam, midazolam o triazolam a traves de una via inhalatoria.
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030144219A1 (en) 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
AU2003239433A1 (en) 2002-05-13 2003-11-11 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
PT1567164E (pt) * 2002-11-26 2009-03-31 Alexza Pharmaceuticals Inc Utilização de loxapina para o fabrico de um medicamento para o tratamento da dor
CN1726037B (zh) * 2002-11-26 2010-05-05 艾利斯达医药品公司 抗精神病药用于制备通过吸入传送治疗头痛的药物中的应用
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8455437B2 (en) * 2005-02-04 2013-06-04 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Method to predict and prevent oxygen-induced inflammatory tissue injury
ITMI20050417A1 (it) * 2005-03-15 2006-09-16 Medestea Res & Production S R L Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
WO2007095039A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
JP5094197B2 (ja) * 2006-04-27 2012-12-12 第一三共ヘルスケア株式会社 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
WO2009134917A2 (en) * 2008-04-29 2009-11-05 Wyeth Methods for treating inflammation
KR101704815B1 (ko) * 2009-08-21 2017-02-09 포항공과대학교 산학협력단 Ｉｌ－１７ 매개 염증질환의 치료를 위한 조합 제제 및 이를 이용한 치료 방법
WO2013152044A1 (en) * 2012-04-02 2013-10-10 The Board Of Regents Of The University Of Texas System Use of pc-nsaids to treat and/or prevent pulmonary inflammation
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
JP2016518388A (ja) * 2013-04-30 2016-06-23 オティトピック インク． 乾燥粉末配合および使用方法
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
WO2016040570A2 (en) 2014-09-12 2016-03-17 Children's Medical Center Corporation Dietary emulsion formulations and methods for using the same
US11723864B2 (en) * 2015-05-29 2023-08-15 The Texas A&M University System Antimicrobial and anti-inflammatory compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244899A (en) * 1985-02-04 1993-09-14 G. D. Searle And Co. Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same

Also Published As

Publication number Publication date
DE69229070D1 (de) 1999-06-10
KR920016086A (ko) 1992-09-24
IL100896A0 (en) 1992-11-15
NO920504L (no) 1992-08-10
CZ281970B6 (cs) 1997-04-16
HU9200389D0 (en) 1992-04-28
CA2060937A1 (en) 1992-08-10
NO179893C (no) 1997-01-08
AU1077292A (en) 1992-08-13
CS35292A3 (en) 1992-08-12
NO179893B (no) 1996-09-30
ZA92890B (en) 1992-12-30
JPH0648958A (ja) 1994-02-22
ATE179605T1 (de) 1999-05-15
MX9200571A (es) 1992-12-01
NZ241542A (en) 1996-05-28
US6051566A (en) 2000-04-18
DE69229070T2 (de) 1999-11-18
AU662509B2 (en) 1995-09-07
BR9200429A (pt) 1992-10-13
HUT60917A (en) 1992-11-30
NO920504D0 (no) 1992-02-07
IE920427A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
US6051566A (en) Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
Tashkin et al. Bronchial effects of aerosolized Δ9-tetrahydrocannabinol in healthy and asthmatic subjects
KR101390579B1 (ko) 정량 흡입기를 사용한 트레프로스티닐 투여
PL199442B1 (pl) Kompozycja farmaceutyczna oparta na związkach antycholinergicznych i beta-mimetycznych oraz jej zastosowanie
CA2024872C (en) Medicaments
JP6300828B2 (ja) 口腔粘膜炎を治療するための口腔殺菌性組成物
AU2005210083A1 (en) Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
LV12201B (en) USE OF NITROGEN OXIDE FOR BRONHOSTENOSE TREATMENT OR PROFILE
SA04250122B1 (ar) دواء جديد يحتوي على العامل المساعد بيتا 2 شديد الفعالية وطويل المفعول وذلك بالاتحاد مع مكونات فعاله أخرى
US5366967A (en) Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
Nuhoğlu et al. Efficacy of aminophylline in the treatment of acute asthma exacerbation in children
EP0499143B1 (en) Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
BRPI0610498A2 (pt) uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar
Bleecker et al. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease
Joos et al. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics
PT866711E (pt) Montirelina para inibição da apneia do sono
Rasmussen et al. Reduced nonspecific bronchial reactivity and decreased airway response to antigen challenge in atopic asthmatic patients treated with the inhaled leukotriene D4 antagonist, L‐648,051
ES2248131T3 (es) Combinacion de loteprednol y agonistas de adrenoceptor beta2 y su utilizacion por inhalacion para el tratamiento del asma bronquial.
Mutoh et al. Effects of nitrous oxide on mask induction of anesthesia with sevoflurane or isoflurane in dogs
NZ260290A (en) Use of a non-steroidal anti-inflammatory drug in the preparation of anti-asthmatic inhalant compositions
WO2010009288A1 (en) Compositions and uses of antiviral active pharmaceutical agents
Godin et al. Acute bronchoconstriction caused by Beclovent and not Vanceril
Watanabe et al. Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol
RU2625766C1 (ru) Средство для экстренного восстановления голоса при внезапной афонии
Sestini et al. Protective Effect of Furosemide, Administered Using a Pressurized Metered Dose Inhaler and a Spacer Device, on the Bronchial Obstructive Response to Ultrasonically Nebulized Distilled Water

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void